MALAT1 and lung cancer: Reports indicate that miR-101-3p targets Pim-1 in salivary gland adenoid cystic carcinoma to enhance the sensitivity to chemotherapy and suppress cell proliferation and invasion (23); miR-101-3p was also reported to target MALAT-1 in nonsmall cell lung cancer to inhibit growth and metastasis (24).